Corcept Therapeutics Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results and Increased FY24 Revenue Guidance Above Estimates.
Corcept Therapeutics Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results and Increased FY24 Revenue Guidance Above Estimates.
Corcept Therapeutics公佈的第一季度財務業績好於預期，且24財年收入預期高於預期，股價走高。
Corcept Therapeutics Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results and Increased FY24 Revenue Guidance Above Estimates.
Corcept Therapeutics公佈的第一季度財務業績好於預期，且24財年收入預期高於預期，股價走高。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。